Macrophage Migration Inhibitory Factor Deficiency in Chronic Obstructive Pulmonary Disease
AJP Lung Cellular and Molecular Physiology
Published online on January 17, 2014
Abstract
The pathogenesis of Chronic Obstructive Pulmonary Disease (COPD) remains poorly understood. Cellular senescence and apoptosis contribute to the development of COPD, however, crucial regulators of these underlying mechanisms remain unknown. Macrophage Migration Inhibitory Factor (MIF) is a pleiotropic cytokine that antagonizes both apoptosis and premature senescence and may be important in the pathogenesis of COPD. This study examines the role of MIF in the pathogenesis of COPD. Mice deficient in MIF (Mif -/-), the MIF receptor CD74 (CD74 -/-), and wild type (WT) controls were aged for 6 months. Both Mif -/- and CD74 -/- mice developed spontaneous emphysema by 6 months of age compared to WT mice as measured by lung volume and chord length. This was associated with activation of the senescent pathway markers p53/21 and p16. Following exposure to cigarette smoke, Mif -/- mice were more susceptible to the development of COPD and apoptosis when compared to WT mice. MIF plasma concentrations were measured in a cohort of 224 human participants. Within a subgroup of older current and former smokers (n=72), MIF concentrations were significantly lower in those with COPD [8.8, 95%CI (6.7-11.0)] compared to those who did not exhibit COPD [12.7, 95%CI (10.6-14.8)]. Our results suggest that both MIF and the MIF receptor CD74 are required for maintenance of normal alveolar structure in mice and that decreases in MIF are associated with COPD in human subjects.